The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@Triplejxox has been approved! / X

Estrogen Receptor

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium - Barron's

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@Cutiepiekim27 has been approved! / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

Artivion announces positive trial results for its On-X mitral valve replacement - MassDevice

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #boobsapprover / X

X 上的The Boobs Approver™ - 1️⃣4️⃣3️⃣k：「Approved! #quarantitties / X

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@littlmisfit has been approved! / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@Isisxoxox has been approved! / X

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@CowboyNSweetT has been approved! / X

Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Follow her on IG! #quarantitties / X